Real-World Treatment and Outcomes of ALK-Positive Metastatic Non–Small Cell Lung Cancer in a Southeast Asian Country
Purpose: Anaplastic lymphoma kinase (ALK) inhibitors are associated with good overall survival (OS) for ALK-positive metastatic non–small cell lung cancer (NSCLC). However, these treatments can be unavailable or limited by financial constraints in developing countries. Using data from a nationwide l...
| 發表在: | Cancer Management and Research |
|---|---|
| 主要作者: | |
| 格式: | Article |
| 語言: | English |
| 出版: |
Dove Medical Press Ltd
2023
|
| 在線閱讀: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85146472874&doi=10.2147%2fCMAR.S393729&partnerID=40&md5=04b390ab75a0d53150b544ff7882d80a |